Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
29,557,283
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
504,217
-
Shares change
-
+504,217
-
Total reported value, excl. options
-
$1,072,636
-
Value change
-
+$1,072,634
-
Number of buys
-
20
-
Price
-
$2.14
Significant Holders of BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY) as of Q3 2023
20 filings reported holding BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share as of Q3 2023.
BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 504,217 shares
of 29,557,283 outstanding shares and own 1.71% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (247,401 shares), GEODE CAPITAL MANAGEMENT, LLC (64,074 shares), Strengthening Families & Communities, LLC (48,263 shares), AE Wealth Management LLC (41,684 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (30,533 shares), STATE STREET CORP (22,548 shares), BlackRock Inc. (13,375 shares), NORTHERN TRUST CORP (12,002 shares), TD Waterhouse Canada Inc. (10,000 shares), and PNC Financial Services Group, Inc. (3,788 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.